Also from this source

You just read:

Argos Therapeutics' Arcelis™ Immunotherapy for Treatment of HIV Demonstrates Positive Outcomes in Viral Load Control and Favorable Safety and Immunogenicity Profile in Final Analysis of Phase 2a Study

News provided by

Argos Therapeutics

Mar 02, 2011, 04:05 EST